These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24930717)

  • 1. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
    Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
    Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
    Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
    Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmin activity in the porcine airways is enhanced during experimental infection with Mycoplasma hyopneumoniae, is positively correlated with proinflammatory cytokine levels and is ameliorated by vaccination.
    Woolley LK; Fell SA; Djordjevic SP; Eamens GJ; Jenkins C
    Vet Microbiol; 2013 May; 164(1-2):60-6. PubMed ID: 23490555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
    Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
    Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of clinical, histological and immunological changes and qPCR detection of Mycoplasma hyopneumoniae in tissues during the early stages of mycoplasmal pneumonia in pigs after experimental challenge with two field isolates.
    Woolley LK; Fell S; Gonsalves JR; Walker MJ; Djordjevic SP; Jenkins C; Eamens GJ
    Vet Microbiol; 2012 Dec; 161(1-2):186-95. PubMed ID: 22863144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Immunization with Attenuated
    Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
    Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
    Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
    Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
    Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
    Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
    Seo HW; Park SJ; Park C; Chae C
    Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
    Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
    Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age.
    Reynolds SC; St Aubin LB; Sabbadini LG; Kula J; Vogelaar J; Runnels P; Peters AR
    Vet J; 2009 Sep; 181(3):312-20. PubMed ID: 18554964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
    de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
    Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.
    Ogawa Y; Oishi E; Muneta Y; Sano A; Hikono H; Shibahara T; Yagi Y; Shimoji Y
    Vaccine; 2009 Jul; 27(33):4543-50. PubMed ID: 19433128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evaluation of
    Kim S; Oh T; Yang S; Cho H; Chae C
    Can J Vet Res; 2021 Jan; 85(1):77-81. PubMed ID: 33390658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.